19125-84-9 Usage
Description
1,6-Dibromonaphthalene is a white crystalline solid with two isomers, primarily recognized for its role as a pharmaceutical intermediate. It is characterized by its ability to act as a ligand for metal ions, such as copper, iron, and zinc, and has demonstrated selectivities for unsymmetrical molecules with unmodified organic ligands.
Uses
Used in Pharmaceutical Industry:
1,6-Dibromonaphthalene is used as a pharmaceutical intermediate for its versatile properties, allowing it to be integrated into the development of various drugs and therapies. Its capacity to serve as a ligand for metal ions, such as copper, iron, and zinc, makes it a valuable component in the creation of metal-based pharmaceuticals.
Additionally, 1,6-Dibromonaphthalene's selectivity for unsymmetrical molecules with unmodified organic ligands contributes to its utility in the design and synthesis of novel pharmaceutical compounds, potentially leading to advancements in drug discovery and development.
Used in Chemical Research:
1,6-Dibromonaphthalene is also utilized in chemical research, particularly in the study of metal-organic interactions and the development of new coordination compounds. Its unique properties as a ligand make it an interesting subject for research, potentially leading to new insights and innovations in the field of chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 19125-84-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,9,1,2 and 5 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 19125-84:
(7*1)+(6*9)+(5*1)+(4*2)+(3*5)+(2*8)+(1*4)=109
109 % 10 = 9
So 19125-84-9 is a valid CAS Registry Number.
19125-84-9Relevant articles and documents
Synthesis, biological evaluation and molecular modelling studies of novel ACD- and ABD-ring steroidomimetics as inhibitors of CYP17
Pinto-Bazurco Mendieta, Mariano A.E.,Negri, Matthias,Jagusch, Carsten,Hille, Ulrike E.,Mueller-Vieira, Ursula,Schmidt, Dirk,Hansen, Klaus,Hartmann, Rolf W.
, p. 267 - 273 (2008/09/17)
Two novel classes of non-steroidal substrate mimetics were synthesised and examined for their potency as inhibitors of human CYP17. Selected compounds were tested for inhibition of hepatic CYP enzymes 3A4, 1A2, 2C9 and 2C19. The most promising compound 15
